TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES

Patent Applications and Registrations

Patent applications and USPTO patent grants for TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES.The latest application filed is for "composition for inhibiting reduction of testosterone and/or dihydrotestosterone".

Company Profile

16.9.15

TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES - Tokyo JP
Tokyo University of Pharmacy & Life Sciences - Hachioji N/A JP
Tokyo University of Pharmacy & Life Sciences - Hachioji-shi, Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Inhibiting Reduction Of Testosterone And/or Dihydrotestosterone App 20220288144 - NAKASONE; Toyokazu ; et al.	2022-09-15
Method For Measuring Beta-1,3-1,6-glucan App 20220276231 - NAKATA; Hidetaka ; et al.	2022-09-01
Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon cancer therapeutic in which said ester compound is used Grant 11,203,565 - Asano , et al. December 21, 2	2021-12-21
Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity Grant 11,071,738 - Asano , et al. July 27, 2	2021-07-27
Nucleic Acid Delivery Composition, And Nucleic Acid-containing Composition App 20210115440 - KANAZAWA; Takanori ; et al.	2021-04-22
Novel Anthranilic Acid-Based Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same App 20200383967 - Asano; Tomoichiro ; et al.	2020-12-10
Therapeutic Agent for Fatty Liver Diseases and Therapeutic Agent for Adiposity App 20200383989 - Asano; Tomoichiro ; et al.	2020-12-10
Novel Amide Compound, and Pin1 Inhibitor, Therapeutic Agent for Inflammatory Diseases and Therapeutic Agent for Cancer That Use the Same App 20200383987 - Asano; Tomoichiro ; et al.	2020-12-10
Selective disulfidation reagent using nitrogen-containing compound and method for producing disulfide-containing compound Grant 10,829,512 - Hayashi , et al. November 10, 2	2020-11-10
Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof Grant 10,550,153 - Hayashi , et al. Fe	2020-02-04
Novel Ester Compound And Pin1 Inhibitor, Inflammatory Disease Therapeutic, And Colon Cancer Therapeutic In Which Said Ester Comp App 20190382330 - Asano; Tomoichiro ; et al.	2019-12-19
Peptide Or Pharmaceutically Acceptable Salt Thereof, Or Prodrug Thereof App 20190359652 - HAYASHI; Yoshio ; et al.	2019-11-28
Peptide Or Pharmaceutically Acceptable Salt Thereof, Or Prodrug Thereof App 20190177370 - HAYASHI; Yoshio ; et al.	2019-06-13
Selective Disulfidation Reagent Using Nitrogen-containing Compound And Method For Producing Disulfide-containing Compound App 20190169228 - Hayashi; Yoshio ; et al.	2019-06-06
Method Of Treating, Or At Least Inhibiting The Onset Of, Urate Transport Failure App 20170218451 - MATSUO; HIROTAKA ; et al.	2017-08-03
Novel Compound, Production Method Therefor, And Application Therefor App 20160304459 - HAYASHI; Yoshio ; et al.	2016-10-20
Method For Evaluating Urate Transport-related Disease Factor And Inflammation-related Disease Factor App 20150080257 - MATSUO; HIROTAKA ; et al.	2015-03-19
Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug Grant 8,940,286 - Matsuo , et al. January 27, 2	2015-01-27

Company Registrations

NCAGE Code

SUB05

TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.